Global Peripheral Vascular Devices Market Strategic Research Report

The global peripheral vascular devices market occupies a critical position at the intersection of cardiovascular medicine and interventional technology, addressing diseases of the arteries, veins, and lymphatic vessels outside the heart and brain. Valued at approximately USD 12.4 billion in 2024, the market encompasses a broad portfolio of diagnostic and therapeutic devices — including peripheral stents, angioplasty balloons, atherectomy systems, inferior vena cava filters, and endovascular grafts — deployed by vascular surgeons, interventional radiologists, and cardiologists worldwide. The rising global burden of peripheral artery disease, which affects an estimated 236 million adults globally according to the Global Burden of Disease study, anchors the commercial case for continued market expansion through 2032.

Three structurally distinct drivers are propelling market growth. First, the epidemiological tailwind from aging populations in North America, Europe, and East Asia is compounding the prevalence of atherosclerosis, chronic venous insufficiency, and deep vein thrombosis, directly expanding the addressable patient pool requiring interventional procedures. Second, the accelerating shift from open surgical repair toward minimally invasive endovascular procedures — driven by shorter hospital stays, lower complication rates, and improved device trackability — is increasing the per-procedure device content and elevating average selling prices for drug-eluting and bioresorbable platform technologies. Third, expanding healthcare infrastructure investment across India, China, Brazil, and Southeast Asia is unlocking previously underserved patient populations who previously lacked access to catheter-based peripheral interventions. A meaningful restraint, however, is the growing reimbursement pressure in developed markets, where payers in the United States and Germany are actively scrutinizing the cost-effectiveness of next-generation drug-coated balloon and atherectomy technologies, creating pricing friction that can extend commercial adoption cycles.

This report provides a comprehensive, data-anchored analysis of the global peripheral vascular devices market from 2019 through 2032, covering product segmentation by device type and clinical application, regional and country-level revenue forecasts, competitive positioning of ten leading manufacturers, and an assessment of emerging technologies reshaping standard of care. The report is designed for corporate strategy teams evaluating portfolio adjacencies, investment analysts building sector models, M&A advisors assessing acquisition targets in the medtech space, and procurement managers benchmarking supplier landscapes.